Founded in the early 1990s, we set out to redefine the role of an API agent, moving beyond transactional interaction to be a value-driven partner within the pharmaceutical industry.

Our approach is built on transparency, open communication, and long term partnerships. Over the years, this has earned us a strong reputation as a trusted and knowledgeable partner within the pahrmaceutical industry.

As the market has evolved, so have we. We have continuously adapted our capabilities, skill set, and service offering to reflecting the increasing complexity of the pharmaceutical landscape, regulatory environment, and global supply chain. Throughout this evolution, we have remained true to our core values and intentionally maintained a focused, agile structure – allowing us to preserve the quality, responsiveness, and personal engagement that define our identity.

We combine deep market understanding with a highly responsive and flexible way of working – allowing us to create real value for both clients and suppliers.

In 2023 we established RJW Pharma, a wholly owned subsidiary, to further expand our capabilities. As consulting-focused entity, RJW Pharma enhances our ability to support partners with strategic, business development, technical, and regulatory guidance – complementing our core representation activities and enabling a more comprehensive and tailored service offering.